Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794989 · ClinicalTrials.gov registry record · NA
Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00794989 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 20 participants.
The verdict
NCT00794989, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
RATIONALE: Ground flaxseed may prevent breast cancer in premenopausal women at increased risk of developing primary breast cancer. PURPOSE: This randomized clinical trial is studying how well flaxseed works in preventing breast cancer in premenopausal women at risk of breast cancer.
Interventions
- OTHER No Intervention
- DIETARY_SUPPLEMENT Ground Flaxseed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00794989
The ClinicalTrials.gov registry entry for NCT00794989 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Intervention is the first listed.
NCT00794989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00794989 about?
NCT00794989 is a clinical study titled "Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer". RATIONALE: Ground flaxseed may prevent breast cancer in premenopausal women at increased risk of developing primary breast cancer. PURPOSE: This randomized clinical trial is studying how well flaxseed works in preventing breast cancer in premenopausal women at risk of breast cancer.
What is the current status of trial NCT00794989?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2008-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00794989?
The interventions under investigation include: No Intervention (OTHER), Ground Flaxseed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00794989?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.